# The 0.65-Point Gap That Europe Used to Reject a Duchenne Gene Therapy - Date: 2026-04-16 - Category: Biotech & Life Sciences Europe rejected a Duchenne gene therapy because of a 0.65-point difference on a motor test. But boys with the disease lose 3-8 points per year. Roche is running a new trial in 100 young boys, hoping longer data changes the calculation. ---